Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Sample Collection for 2020-2021 Fluzone Formulations
NCT04551677Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated), Efluelda in influenza, sponsored by Sanofi. Started Sep 2020; status: completed.
02
Drugs
Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)Efluelda
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04551677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551677.